CASSANDRA TAMAYO: Open Payments
NPI 1326578089 · GROVE CITY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$553 in 29 payments from 16 companies in 2025. Trend: 2023 $427 · 2024 $461 · 2025 $553
Food & beverage: $553
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $72 |
| ABBVIE INC. | 4 | $67 |
| AstraZeneca Pharmaceuticals LP | 4 | $66 |
| Exact Sciences Corporation | 2 | $51 |
| Lilly USA, LLC | 2 | $35 |
| GlaxoSmithKline, LLC. | 2 | $34 |
| Merck Sharp & Dohme LLC | 2 | $34 |
| PFIZER INC. | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
Products named: Dexcom G6 Transmitter, Cologuard Collection Kit, TRELEGY ELLIPTA, VRAYLAR, FARXIGA, CAPLYTA, GVOKE HYPOPEN, Veozah.
Industry payments across OH — which companies pay providers there.
